Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria Luz Pellon"'
Autor:
Mónica Jorge Fernández, Maria Luz Pellon Augusto, J. Méndez, Ana Montes, Juan de la Cámara Gómez, Mercedes Salgado Fernández, Margarita Reboredo Lopez, Nieves Martinez Lago, Guillermo Alfonso Quintero Aldana, Paula González Villaroel, Marta Covela Rúa, Jesús García Gómez, Begoña Graña Suárez
Publikováno v:
Cancer Medicine
Purpose The phase III VELOUR trial demonstrated efficacy with combined FOLFIRI‐aflibercept in patients with metastatic colorectal cancer previously treated with oxaliplatin with or without bevacizumab versus placebo. The effect of FOLFIRI‐afliber
Autor:
Paula Cerdá, Elvira Buxó, Eduardo Ceballos, Lorena Paris, Antia Cousillas, Jorge Aparicio, Nieves Martinez Lago, Alberto Molero, Silvia Díaz-Cerezo, Raquel Molina, Carlos Romero, Ricardo Yaya, Laura Diaz-Paniagua, María Ortega, Mónica Jorge, Federico Longo, Ana Montes, Maria Luz Pellon, Pedro Lopez Leiva, Min-Hua Jen, Alfonso Martín Carnicero, Ana Maria Lopez, Guillermo Quintero, Sergio de la Torre, Elena Brozos, Beatriz García-Paredes
Publikováno v:
FUTURE ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Aims: To obtain real-world data on ramucirumab use and effectiveness for the treatment of advanced gastric cancer (AGC) or gastroesophageal junction adenocarcinoma (GEJ). Methods: Observational, retrospective study carried out in 20 Spanish hospitals
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carlos Méndez Méndez, Begoña Graña Suárez, Sonia Candamio Folgar, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Marta Covela Rúa, Elena Brozos Vazquez, Carlos Grande Ventura, Juan de la Cámara Gómez, Alberto Carral Maseda, Francisca Vázquez Rivera, Mercedes Salgado Fernández, Mónica Jorge Fernández, Marta Carmona Campos, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Ana Montes, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto
Publikováno v:
Journal of Clinical Oncology. 37:620-620
620 Background: Activating B-type Raf kinase (BRAF) mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E)mt is a strong predictor of a poor prognosis, with distinct clini
Autor:
Begoña Graña Suárez, Juan de la Cámara Gómez, Carlos Méndez Méndez, Elena Gallardo Martin, Nieves Martinez Lago, Maria Luz Pellon Augusto, Margarita Reboredo Lopez, Antia Cousillas Castiñeira, Sonia Candamio Folgar, Carlos Grande Ventura, Guillermo Alfonso Quintero Aldana, Paula Gonzalez Villarroel, Elena Brozos Vazquez, Mónica Jorge Fernández, Marta Covela Rúa, Ana Montes, Francisca Vázquez Rivera, Marta Carmona Campos, Mercedes Salgado Fernández, Alberto Carral Maseda
Publikováno v:
Journal of Clinical Oncology. 37:622-622
622 Background: Multiple studies have reported prognostic association of neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLT) and albumin levels including patients with early and advanced metastatic colorectal cancer. However, it
Autor:
Margarita Reboredo, Maria Luz Pellon, M. Salgado Fernandez, J.C. Méndez Méndez, P. Gonzalez Villarroel, A. Fernández-Montes, C. Romero Reinoso, Manuel Valladares-Ayerbes, M. Mesa Ramos, M. Covela, J. De la Cámara Gómez, M. Jorge Fernandez, G. Quintero Aldana
Publikováno v:
Annals of Oncology. 28:v187-v188
Autor:
Mercedes Salgado Fernández, Antia Cousillas, Elena Brozos Vazquez, Mónica Jorge Fernández, Maria Luz Pellon Augusto, Begoña Graña, Ana Montes, Yolanda Vidal Insua, Paula Gonzalez Villarroel, Carlos Romero Reinoso, Marta Carmona Campos, Jose Carlos Mendez, Juan De la camara, Francisca Vázquez Rivera, Guillermo Alfonso Quintero Aldana, Sonia Candamio Folgar, Elena Gallardo Martin, Nieves Martinez Lago, Marta Covela Rúa, Margarita Reboredo Lopez
Publikováno v:
Journal of Clinical Oncology. 36:e15561-e15561
e15561Background: BRAF mutations, mostly missense V600E, occur in approximately 8% to 12% of patients with metastatic colorectal cancer (mCRC). BRAF (V600E) mt is a strong predictor of a poor progn...
Autor:
Ana Fernandez-Montes, Ana Medina, Carlos Romero Reinoso, Guillermo Quintero, Mónica Jorge, M. Salgado, Maria Luz Pellon, Margarita Reboredo, Asociacion Grupo Gallego de Investigacion en Tumores Digestivos
Publikováno v:
Journal of Clinical Oncology. 30:649-649
649 Background: In ASCO2004, Y. Fernandez et al. showed their experience in gemcitabine/capecitabine use in patients with metastatic advanced colorectal cancer (ACRC), with previous progression or contraindicated standar treatment, with encouraging r
Autor:
Ana Fernández Montes, Nieves Martinez-Lago, Juan de la Cámara Gomez, Elena María Brozos Vázquez, Sonia Candamio Folgar, Marta Carmona Campos, Antía Cousillas Castiñeiras, Marta Covela Rúa, Elena Gallardo Martín, Paula González Villarroel, Begoña Graña Suarez, Mónica Jorge Fernández, María Luz Pellón Augusto, Guillermo Quintero Aldana, Carlos Romero Reinoso, Mercedes Salgado Fernández, Francisca Vázquez Rivera, Ana Ayuso Álvarez, Dante R. Culqui, José Carlos Méndez Méndez, RIGhT-sens Working Group
Publikováno v:
Healthcare, Vol 9, Iss 6, p 665 (2021)
Background: In recent years, abundant scientific evidence has been generated based on clinical trials (CT) in the field of oncology. The general objective of this paper is to find out the extent to which decision making is based on knowledge of the m
Externí odkaz:
https://doaj.org/article/01792a8c5c8744f0a15982e2682a7257
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.